Tag
FACIT
Jun 23, 2020
FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund
FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund
Jun 09, 2020
FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)
FACIT recognized with 2020 Venture Capital Regional Impact Award by the Canadian Venture Capital & Private Equity Association (CVCA)
Nov 06, 2019
FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research
FACIT launches assessment of venture philanthropy models to scale Canadian commercialization of cancer research
Oct 30, 2019
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
FACIT and University of Toronto launch precision medicine company: Cellular Analytics
Sep 26, 2019
FACIT's Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies
FACIT's Prospects Oncology Fund invests in Ontario-developed medical device and novel therapeutic platform technologies
Jun 18, 2019
From idea to impact: An expanding solution to a common surgical problem
From idea to impact: An expanding solution to a common surgical problem
Apr 09, 2019
Entrepreneurs from Ontario's Nanology Labs and Xpan Inc. receive FACIT investment for early-stage cancer innovations 
Entrepreneurs from Ontario's Nanology Labs and Xpan Inc. receive FACIT investment for early-stage cancer innovations 
Mar 27, 2019
The winner of last year’s FACIT Falcons’ Fortunes pitch competition is already seeing early success in moving her product to the clinic
The winner of last year’s FACIT Falcons’ Fortunes pitch competition is already seeing early success in moving her product to the clinic
Feb 07, 2019
Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene
Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene
Jan 29, 2019
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
FACIT and Triphase Accelerator Announce New Partnership with Celgene for First-in-class WDR5 Leukemia Therapy
Jan 29, 2019
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
Jan 10, 2019
FACIT makes follow-on investment in AI-based genomics company, DNAstack
FACIT makes follow-on investment in AI-based genomics company, DNAstack
Oct 11, 2018
FACIT Welcomes Har Grover and Ken Lawless to the Board
FACIT Welcomes Har Grover and Ken Lawless to the Board
Sep 13, 2018
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
Aug 22, 2018
Heliotrope: Personalizing cancer treatment decisions
Heliotrope: Personalizing cancer treatment decisions
Aug 02, 2018
Ontario centre attracts national attention for probe research, development and commercialization
Ontario centre attracts national attention for probe research, development and commercialization
Jun 27, 2018
Healthcare Software Start-Up Ziliomics Financed by FACIT
Healthcare Software Start-Up Ziliomics Financed by FACIT
Jun 13, 2018
FACIT Appoints Biotech Veteran Dr. David O'Neill as President
FACIT Appoints Biotech Veteran Dr. David O'Neill as President
Apr 12, 2018
Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
Restorative Breast Cancer Solution Start-Up Wins the 2018 FACIT Pitch Competition
Feb 21, 2018
FACIT invests $450k in promising Ontario breakthrough technologies
FACIT invests $450k in promising Ontario breakthrough technologies
Dec 04, 2017
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Nov 22, 2017
FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees
FACIT Welcomes Kevin Empey, Cynthia Goh and Shana Kelley to the Board of Trustees
Oct 04, 2017
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
FACIT Portfolio Company Fusion Pharmaceuticals Closes US$46M Oversubscribed Series A
Sep 29, 2017
OICR 2016/17 Annual Report
OICR 2016/17 Annual Report
Aug 01, 2017
FACIT launches cross-border campaign to recruit clinical scientists and biotechnology industry executives
FACIT launches cross-border campaign to recruit clinical scientists and biotechnology industry executives
Aug 01, 2017
FACIT announces investment in three Ontario start-ups under Prospects Fund
FACIT announces investment in three Ontario start-ups under Prospects Fund
Mar 22, 2017
FACIT Launches The Prospects Oncology Fund
FACIT Launches The Prospects Oncology Fund
Mar 22, 2017
FACIT Announces Investment in Propellon Therapeutics
FACIT Announces Investment in Propellon Therapeutics
Feb 23, 2017
FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A  Led by Johnson & Johnson Innovation
FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation
Nov 02, 2016
FACIT start-up Turnstone Biologics closes USD $41M financing
FACIT start-up Turnstone Biologics closes USD $41M financing
Oct 05, 2016
From our Annual Report: Investing in the cure and the economy
From our Annual Report: Investing in the cure and the economy
Sep 27, 2016
Annual report for the Ontario Institute for Cancer Research
Annual report for the Ontario Institute for Cancer Research
Sep 19, 2016
Open resource: How we’re making our research resources more accessible to the community
Open resource: How we’re making our research resources more accessible to the community
Jul 04, 2016
FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight
FACIT Falcons’ Fortunes pitch competition helps Ontario ideas take flight
Jun 23, 2016
Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers
Propellon Therapeutics to Accelerate WDR5 Inhibitor Development for Cancers
Jun 07, 2016
OICR attends BIO International 2016 in San Francisco
OICR attends BIO International 2016 in San Francisco
May 26, 2016
Privacy Analytics Acquired by IMS Health
Privacy Analytics Acquired by IMS Health
Mar 16, 2016
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
FACIT invests in new CPDC spin-out company to aid development of potent radiotherapeutic
Jan 28, 2016
Trillium Therapeutics Acquires Fluorinov Pharma
Trillium Therapeutics Acquires Fluorinov Pharma
Dec 29, 2015
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
Dec 16, 2015
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
FACIT Announces Investment in Fusion Pharmaceuticals and Alpha-Emitting Radiotherapeutics
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Nov 09, 2015
FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership
FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership
Oct 28, 2015
FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management
FACIT Startup Turnstone Biologics Closes $11M Financing, Secures Additional Capital Commitment, and Adds Strong Management
Jan 07, 2015
Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers
Fluorinov Pharma and FACIT Announce Investment in Breakthrough Bromodomain Inhibitors for the Treatment of Cancers